Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis A Krumme

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
AJOG Global Reports|March 4, 2025
Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunizationAlexis A Krumme, Robert Y Suruki, Clair Blacketer, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2015
Association between trajectories of statin adherence and subsequent cardiovascular eventsJessica M Franklin, Alexis A Krumme, Angela Y Tong, et al.
Annals of Internal Medicine|March 17, 2015
Cost-effectiveness of novel regimens for the treatment of hepatitis C virusMehdi Najafzadeh, Karin Andersson, William H Shrank, et al.
Journal of General Internal Medicine|July 29, 2018
Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USAJessica M Franklin, Mufaddal Mahesri, Alexis A Krumme, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2018
Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health BehaviorsJulie C Lauffenburger, Jessica M Franklin, Alexis A Krumme, et al.
American Heart Journal|February 16, 2018
The relative benefits of claims and electronic health record data for predicting medication adherence trajectoryJessica M Franklin, Chandrasekar Gopalakrishnan, Alexis A Krumme, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014Jeffrey A Sparks, Alexis A Krumme, William H Shrank, et al.
Journal of Comparative Effectiveness Research|December 22, 2017
Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research studyAlexis A Krumme, Ajinkya Pawar, Sebastian Schneeweiss, et al.
The American Journal of Managed Care|November 4, 2014
Quality of care at retail clinics for 3 common conditionsWilliam H Shrank, Alexis A Krumme, Angela Y Tong, et al.
JAMA Network Open|March 16, 2019
Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical TrialJulie C Lauffenburger, Jennifer Lewey, Saira Jan, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
AJOG Global Reports|March 4, 2025
Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunizationAlexis A Krumme, Robert Y Suruki, Clair Blacketer, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2015
Association between trajectories of statin adherence and subsequent cardiovascular eventsJessica M Franklin, Alexis A Krumme, Angela Y Tong, et al.
Annals of Internal Medicine|March 17, 2015
Cost-effectiveness of novel regimens for the treatment of hepatitis C virusMehdi Najafzadeh, Karin Andersson, William H Shrank, et al.
Journal of General Internal Medicine|July 29, 2018
Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USAJessica M Franklin, Mufaddal Mahesri, Alexis A Krumme, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2018
Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health BehaviorsJulie C Lauffenburger, Jessica M Franklin, Alexis A Krumme, et al.
American Heart Journal|February 16, 2018
The relative benefits of claims and electronic health record data for predicting medication adherence trajectoryJessica M Franklin, Chandrasekar Gopalakrishnan, Alexis A Krumme, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014Jeffrey A Sparks, Alexis A Krumme, William H Shrank, et al.
Journal of Comparative Effectiveness Research|December 22, 2017
Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research studyAlexis A Krumme, Ajinkya Pawar, Sebastian Schneeweiss, et al.
The American Journal of Managed Care|November 4, 2014
Quality of care at retail clinics for 3 common conditionsWilliam H Shrank, Alexis A Krumme, Angela Y Tong, et al.
JAMA Network Open|March 16, 2019
Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical TrialJulie C Lauffenburger, Jennifer Lewey, Saira Jan, et al.
Pageof 4